216 Views

Harvest and Cressey recaps VetCor

Harvest Partners LP and Cressey & Company LP has led a recapitalization of VetCor Group Holdings Corp. No financial terms were disclosed. Jefferies LLC provided financial advice to VetCor on the transaction while Golub Capital arranged the senior debt. Headquartered in Hingham, Massachusetts, VetCor is an owner and operator of veterinary hospitals.

VC-backed Cidara Therapeutics rolls out IPO

San Diego-based biotech company Cidara Therapeutics has raised $76.8 million for its IPO after pricing its 4.8 million shares at $16 per share. The stock begins trading Wednesday on the NASDAQ under the ticker symbol “CDTX.” Jefferies LLC and Leerink Partners are the lead underwriters. Cidara’s backers include 5AM Ventures, Aisling Capital, Frazier Healthcare and InterWest Partners.

240 Views

Warburg Pincus and GTCR to recap Sterigenics

Warburg Pincus and GTCR will recapitalize Sterigenics International, a provider of contract sterilization, gamma technologies and medical isotopes. No financial terms were disclosed. The transaction is expected to be completed in the second quarter of this year. Goldman, Sachs & Co. and Jefferies LLC were financial advisors to Sterigenics and GTCR while J.P. Morgan Securities LLC provided additional financial advice to GTCR. Also, JPMorgan will provide debt financing for the recap. Sterigenics is owned by GTCR.

VC-backed Cidara Therapeutics files for IPO

San Diego-based biotech company Cidara Therapeutics has filed for a $69 million IPO, according to an SEC filing. The company plans on trading on the NASDAQ under the ticker symbol “CDTX.” Jefferies and Leerink Partners are listed as lead underwriters. Cidara’s backers include 5AM Ventures, Aisling Capital, Frazier Healthcare and InterWest Partners.

128 Views

VC-backed Flex Pharma files for IPO

According to an SEC filing, Boston-based Flex Pharma, a biotech firm that focuses on treating muscle cramps, has filed for an IPO. Although the number of shares that will be sold as well as the stock’s pricing terms have yet to be set, the document proposes the IPO’s value to be up to $60 million Jefferies and Piper Jaffray are among those named as lead underwriters. Flex Pharma’s backers include Bessemer Venture Partners and Longwood Fund.

 

143 Views

PE-backed AltheaDx files for IPO

AltheaDx, a molecular diagnostics firm, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. AltheaDx plans on listing its stock on the NASDAQ under the ticker symbol “IDGX.” Citigroup and Jefferies are the lead underwriters. AltheaDx’s backers include Telegraph Hill Partners.

Revellers chat on a street before performing at a carnival parade in Havana
491 Views

peHUB Second Opinion

In Second Opinion, Sony cancels the premier of “The Interview,” the U.S. restores diplomatic relations with Cuba and what to do when a VC says no, over and over again.

156 Views

Investing platform Insikt fetches $16 mln

Investing platform Insikt has raised $16 million in Series B funding, it was announced on the company’s site. Revolution Ventures led the round with participation from other investors that included Firstmark Capital, Serengeti Asset Management, Peterson Ventures, Jefferies and Atalaya Capital Management. To read the post, visit here.

 

168 Views

Athletico Physical Therapy closes buy of Accelerated Rehab

Athletico Physical Therapy, which is backed by Harvest Partners, has acquired Accelerated Rehabilitation Centers from OMERS Private Equity. Financial terms weren’t announced. The deal, announced in November, closed December 2. Jefferies provided financial advice to accelerated.

150 Views

Wayzata-owned Neff Corp. goes public

Neff Corp., a regional equipment rental firm, has debuted its IPO after pricing its over 10 million shares at $15 per share. The stock began trading Friday on the NYSE under the ticker symbol “NEFF.” Morgan Stanley, Jefferies, Piper Jaffray and Merrill Lynch, Pierce, Fenner & Smith are the lead underwriters. Neff filed for bankruptcy in May 2010 and emerged from Chapter 11 a few months later. It was later acquired by Wayzata Investment Partners.

227 Views

Pamplona buys majority stake in Intralign

Pamplona has acquired a majority stake in Intralign, which is backed by Heritage Group and Cardinal Health. Jefferies and Lowenstein Sandler advised Pamplona on the transaction. Based in Scottsdale, Arizona, Intralign is a specialty healthcare services firm.

183 Views

Israeli pharma firm NeuroDerm debuts IPO

Israel-based NeuroDerm, a pharmaceutical firm that develops drugs for CNS diseases, has raised $45 million after pricing its 4.5 million shares at $10 per share. The stock began trading Friday on the NASDAQ under the ticker symbol “NDRM.” Jefferies and Cowen and Company are the lead underwriters. NeuroDerm’s backers include The Elias Group.

PE HUB Community

Join the 12515 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget